Requires health insurance coverage of diagnostic and supplemental breast examinations without cost-sharing.
Impact
If enacted, SB 1275 will affect both individual and group health insurance policies in the State of New Jersey. It will require that all contracts approved by the Commissioner of Banking and Insurance include provisions for breast examinations, thus making it illegal to impose cost-sharing requirements such as deductibles, copayments, or coinsurance. This change could potentially increase the accessibility of breast cancer screenings among state residents, particularly benefiting those who are uninsured or underinsured.
Summary
Senate Bill 1275 is a proposed legislation that mandates health insurance coverage for diagnostic and supplemental breast examinations without any cost-sharing requirements. This bill intends to ensure that individuals covered under various health insurance plans are able to access necessary diagnostic tests for breast cancer screening without incurring additional out-of-pocket expenses. It emphasizes coverage in line with the National Comprehensive Cancer Network Guidelines, which dictate that these examinations should be medically necessary.
Contention
While the bill aims to enhance access to critical health services for breast cancer screening, there may be points of contention regarding its financial implications for insurance providers. Stakeholders could raise concerns about the potential increase in premiums or changes in policy structures required to comply with the legislation. Additionally, discussions may arise concerning the implications for coverage under high-deductible health plans and its alignment with federal regulations pertaining to health savings accounts. Advocates may also highlight the necessity of early detection in improving health outcomes, strengthening the case for the bill.